Covid-19 evolves naturally, finds new research

Image Source : AP A pharmacist prepares a syringe from a vial of the AstraZeneca coronavirus vaccine.
New research have instructed that Covid-19 developed naturally and is much extra widespread than beforehand believed, a media report stated.

“At least four recent studies have identified coronaviruses closely related to the pandemic strain in bats and pangolins in Southeast Asia and Japan, a sign that these pathogens are more widespread than previously known and that there was ample opportunity for the virus to evolve,” The Wall Street Journal stated on Monday.

Another research has discovered {that a} change in a single amino acid — an natural compound to kind proteins — on the spike protein of the virus can permit the virus to contaminate human cells, the newspaper added.

ALSO READ | UK to obtain 10 million AstraZeneca COVID-19 vaccine doses from India

“These latest pieces of research add to evidence that the virus, called SARS-CoV-2, likely originated in bats and then evolved naturally to infect humans, possibly through an intermediary animal,” it stated.

The research additionally clarify why a workforce of specialists led by the World Health Organization (WHO) who completed their area research within the central Chinese metropolis of Wuhan final month urged wanting additional afield for knowledge and proof in different international locations, the Xinhua information company reported.

The WHO knowledgeable workforce, comprising specialists from Australia, Denmark, Germany, Japan, the Netherlands, Qatar, Russia, Britain, the US and Vietnam, arrived in China’s Wuhan on January 14 to work with Chinese scientists on origin-tracing of the novel coronavirus.

In early February, the worldwide workforce concluded their month-long analysis and offered their preliminary findings at a press convention in China, ruling out the speculation that the virus escaped from a laboratory, and calling for science-based approaches.

ALSO READ | COVAXIN exhibits interim efficacy of 81% in part 3 scientific trials

 
Latest India News